BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

CooperVision Opens Global Innovation Hub in UK, Unveils Six Contact Lens Advancements

CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced si...

September 25, 2026 | News

Astellas Doses First Patient in Phase 3 Trial of Setidegrasib for KRAS G12D-Mutated Lung Cancer

Study evaluates novel, investigational KRAS G12D-targeted protein degrader setidegrasib versus docetaxel in previously treated patients with advanc...

September 25, 2026 | News

Mayo Clinic Laboratories Invests in Pathology Asia to Expand Precision Diagnostics Across APAC

Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to a...

September 23, 2026 | News

IMPACT Therapeutics, Pharmanovia’s Senaparib Secures EU Panel Backing for Ovarian Cancer

MPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based...

September 21, 2026 | News

Massive Bio Targets South Korea Expansion for AI-Powered Oncology Trial Matching

US healthtech company Massive Bio has appointed international business development consultancy Intralink to support its expansion into South Korea and buil...

September 21, 2026 | News

Ferronova’s Nanoparticle Platform Shows Promise for More Precise Gastric and Oesophageal Cancer Surgery

Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesopha...

September 17, 2026 | News

Takeda’s Zasocitinib Receives US FDA Priority Review for Plaque Psoriasis

-Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for za...

September 16, 2026 | News

Bausch + Lomb Secures European CE Mark for Next-Generation SeeLyra Femtosecond Laser

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced European C...

September 14, 2026 | News

MEDIPAL, JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome

-MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the first participa...

September 14, 2026 | News

Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201

Exegenesis Bio and Modalis Therapeutics Corporation (TOKYO: 4883; "Modalis") announced that they have signed a research collaboration and license agr...

September 14, 2026 | News

HORIEN Secures Thai FDA Class 4 Approvals for Three Regenerative Medical Devices

Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying glob...

September 09, 2026 | News

Where the Longevity Money Actually Goes

METHOD IN BRIEF Window: 1 January to 31 August 2026 for round-level claims, with full-year 2024 and 2025 figures for context. Attribution follows scientif...

September 07, 2026 | Analysis

GE HealthCare, Tucker Medical Partner to Advance Imaging Excellence in Southeast Asia

Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia Tucker Medical has installed a SIGNA&trad...

September 07, 2026 | News

Dimerix Secures A$34M Non-Dilutive Funding to Advance Kidney Disease Pipeline Subheadline:

Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lend...

September 07, 2026 | News

Stay Connected